Novel clinical and diagnostic aspects of antineutrophil cytoplasmic antibodies

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Schulte Pelkum, Johannes ^a   Radice, Antonella ^b   Norman, Gary L ^a   Lpez Hoyos, Marcos ^c   Lakos, Gabriella ^a   Buchner, Carol ^a   Musset, Lucile ^d   Miyara, Makoto ^b   Stinton, Laura ^e   Mahler, Michael ^a  

^a INOVA DIAGNOSTICS INC   (United States)

^b SAN CARLO BORROMEO HOSPITAL   (Italy)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY; BIOLOGICAL MARKER;

ANCA ASSOCIATED VASCULITIS; ANTIBODY DETECTION; CHEMILUMINESCENCE IMMUNOASSAY; CLINICAL EVALUATION; CROHN DISEASE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DIGITAL IMAGING; EMERGENCY CARE; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GRANULOMATOSIS; HISTORICAL RESEARCH; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE; INFLAMMATORY BOWEL DISEASE; LATERAL FLOW ASSAY; MEDICAL RESEARCH; MICROSCOPIC POLYANGIITIS; MOLECULAR BIOLOGY; NOMENCLATURE; NONHUMAN; PATHOGENICITY; REVIEW; ULCERATIVE COLITIS; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; BLOOD; DIAGNOSTIC USE; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASES; PROCEDURES; STANDARDS;

ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOLOGICAL MARKERS; HUMANS; IMMUNOASSAY; INFLAMMATORY BOWEL DISEASES;

EID: 84903555001     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/185416     Document Type: Review

References (101)

1. Radice A., Sinico R. A., Antineutrophil cytoplasmic antibodies (ANCA). Autoimmunity 2005 38 1 93 103 2-s2.0-17144412184 10.1080/08916930400022673 (Pubitemid 40515009)
2. Davies D. J., Moran J. E., Niall J. F., Ryan G. B., Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? British Medical Journal 1982 285 6342 606 2-s2.0-0000652834 (Pubitemid 12042688)
3. Wiik A., Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS, Supplement 1989 97 6 12 13 2-s2.0-0024349557 (Pubitemid 19172851)
4. van der Woude F. J., Rasmussen N., Lobatto S., Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. The Lancet 1985 1 8426 425 429 2-s2.0-0021933126 (Pubitemid 15173133)
5. Falk R. J., Jennette J. C., Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. The New England Journal of Medicine 1988 318 25 1651 1657 2-s2.0-0023878734
6. Niles J. L., McCluskey R. T., Ahmad M. F., Arnaout M. A., Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase. Blood 1989 74 6 1888 1893 2-s2.0-0024435458 (Pubitemid 19269085)
7. Jennette J. C., Wilkman A. S., Falk R. J., Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. American Journal of Pathology 1989 135 5 921 930 2-s2.0-0024389175 (Pubitemid 20009502)
8. Kain R., Matsui K., Exner M., Binder S., Schaffner G., Sommer E. M., Kerjaschki D., A novel class of autoantigens of anti-neutrophil cytoplasmic antibodies in necrotizing and crescentic glomerulonephritis: the lysosomal membrane glycoprotein h-lamp-2 in neutrophil granulocytes and a related membrane protein in glomerular endothelial cells. Journal of Experimental Medicine 1995 181 2 585 597 2-s2.0-0028939428 10.1084/jem.181.2.585
9. Talor M. V., Stone J. H., Stebbing J., Barin J., Rose N. R., Burek C. L., Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA). Clinical and Experimental Immunology 2007 150 1 42 48 2-s2.0-34548542324 10.1111/j.1365-2249.2007.03453.x (Pubitemid 47383288)
10. Savige J. A., Davies D. J., Gatenby P. A., Anti-neutrophil cytoplasmic antibodies (ANCA): their detection and significance: report from workshops. Pathology 1994 26 2 186 193 2-s2.0-0028419560
11. Radice A., Bianchi L., Sinico R. A., Anti-neutrophil cytoplasmic autoantibodies: methodological aspects and clinical significance in systemic vasculitis. Autoimmunity Reviews 2013 12 487 495
12. Radice A., Sabadini E., Sinico A., Shoenfeld Y., Gershwin M. E., Meroni P. L., Antineutrophil antibodies with specificity for Proteinase 3. Autoantibodies 2007 2nd Oxford, UK Elsevier 105 110
13. Kallenberg C., Shoenfeld Y., Gershwin M. E., Meroni P. L., Antineutrophil antibodies with specificity for Myeloperoxidase. Autoantibodies 2007 2nd Oxford, UK Elsevier 95 103
14. Seo P., Stone J. H., The antineutrophil cytoplasmic antibody-associated vasculitides. American Journal of Medicine 2004 117 1 39 50 2-s2.0-2942735275 10.1016/j.amjmed.2004.02.030 (Pubitemid 38798019)
15. Jennette J. C., Falk R. J., Bacon P. A., 2012 revised international Chapel Hill consensus Conference nomenclature of vasculitides. Arthritis & Rheumatology 2013 65 1 11
16. Jennette J. C., Falk R. J., Hu P., Xiao H., Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis. Annual Review of Pathology 2013 8 139 160
17. Mahler M., Radice A., Yang W., Bentow C., Seaman A., Bianchi L., Sinico R. A., Development and performance evaluation of novel chemiluminescence assays for detection of anti-PR3 and anti-MPO antibodies. Clinica Chimica Acta 2012 413 7-8 719 726 2-s2.0-84857652808 10.1016/j.cca.2012.01.004
18. Mahler M., Seaman A., Yang W., Engstler G., Comparison of QUANTA Flash MPO with three other assays for the detection of MPO-ANCA. Proceedings of the International Congress on Controversies in Rheumatology and Autoimmunity (CORA '13) 2013 Budapest, Hungary
19. Arias-Loste M. T., Bonilla G., Moraleja I., Presence of anti-proteinase 3 antineutrophil cytoplasmic antibodies (anti-PR3 ANCA) as serologic markers in inflammatory bowel disease. Clinical Reviews in Allergy & Immunology 2013 45 1 109 116
20. Roozendaal C., Kallenberg C. G. M., Are anti-neutrophil cytoplasmic antibodies (ANCA) clinically useful in inflammatory bowel disease (IBD)? Clinical and Experimental Immunology 1999 116 2 206 213 2-s2.0-0032948263 10.1046/j.1365-2249.1999.00905.x (Pubitemid 29219714)
21. Deniziaut G., Ballot E., Johanet C., Antineutrophil cytoplasmic auto-antibodies (ANCA) in autoimmune hepatitis and primary sclerosing cholangitis. Clinics and Research in Hepatology and Gastroenterology 2013 37 105 107
22. Lochman I., Král V., Lochmanová A., LupaC J., Cebecauer L., ANCA in the diagnosis of neutrophil-mediated inflammation. Autoimmunity Reviews 2011 10 6 295 298 2-s2.0-79953163280 10.1016/j.autrev.2010.11.003
23. Savige J., Gillis D., Benson E., Davies D., Esnault V., Falk R. J., Hagen E. C., Jayne D., Jennette J. C., Paspaliaris B., Pollock W., Pusey C., Savage C. O. S., Silvestrini R., van der Woude F., Wieslander J., Wiik A., International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). American Journal of Clinical Pathology 1999 111 4 507 513 2-s2.0-0033037938 (Pubitemid 29153147)
24. Chen M., Kallenberg C. G. M., New advances in the pathogenesis of ANCA-associated vasculitides. Clinical and Experimental Rheumatology 2009 27 1 S108 S114 2-s2.0-70450235126
25. Kain R., Exner M., Brandes R., Ziebermayr R., Cunningham D., Alderson C. A., Davidovits A., Raab I., Jahn R., Ashour O., Spitzauer S., Sunder-Plassmann G., Fukuda M., Klemm P., Rees A. J., Kerjaschki D., Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nature Medicine 2008 14 10 1088 1096 2-s2.0-53549100724 10.1038/nm.1874
26. Roth A. J., Brown M. C., Smith R. N., Badhwar A. K., Parente O., Chung H. C., Bunch D. O., McGregor J. G., Hogan S. L., Hu Y., Yang J.-J., Berg E. A., Niles J., Jennette J. C., Preston G. A., Falk R. J., Anti-LAMP-2 antibodies are not prevalent in patients with antineutrophil cytoplasmic autoantibody glomerulonephritis. Journal of the American Society of Nephrology 2012 23 3 545 555 2-s2.0-84857991096 10.1681/ASN.2011030273
27. Kessenbrock K., Krumbholz M., Schönermarck U., Back W., Gross W. L., Werb Z., Gröne H.-J., Brinkmann V., Jenne D. E., Netting neutrophils in autoimmune small-vessel vasculitis. Nature Medicine 2009 15 6 623 625 2-s2.0-67349279881 10.1038/nm.1959
28. Brinkmann V., Reichard U., Goosmann C., Fauler B., Uhlemann Y., Weiss D. S., Weinrauch Y., Zychlinsky A., Neutrophil Extracellular Traps Kill Bacteria. Science 2004 303 5663 1532 1535 2-s2.0-1542287347 10.1126/science.1092385 (Pubitemid 38314426)
29. Kaplan M. J., Neutrophils in the pathogenesis and manifestations of SLE. Nature Reviews Rheumatology 2011 7 12 691 699 2-s2.0-82955233986 10.1038/nrrheum.2011.132
30. Sangaletti S., Tripodo C., Chiodoni C., Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity. Blood 2012 120 3007 3018
31. Conrad K., Schößler W., Hiepe F., Fritzler M., Conrad K., Schößler W., Hiepe F., Pabst F. M., Myeloperoxidase antibodies. Autoantibodies in Systemic Autoimmune Diseases-A Diagnostic Reference 2007 2nd 111 113
32. Conrad K., Schößler W., Hiepe F., Fritzler M., Conrad K., Schößler W., Hiepe F., Pabst F. M., Proteinase 3 antibodies. Autoantibodies in Systemic Autoimmune Diseases-A Diagnostic Reference 2007 2nd 147 149
33. Savige J., Dimech W., Fritzler M., Goeken J., Hagen E. C., Jennette J. C., McEvoy R., Pusey C., Pollock W., Trevisin M., Wiik A., Wong R., Addendum to the International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies: quality control guidelines, comments, and recommendations for testing in other autoimmune diseases. American Journal of Clinical Pathology 2003 120 3 312 318 2-s2.0-10744224339 10.1309/WAEP-ADW0-K4LP- UHFN (Pubitemid 37295101)
34. Hagen E. C., Daha M. R., Hermans J., Andrassy K., Csernok E., Gaskin G., Lesavre P., Lüdemann J., Rasmussen N., Sinico R. A., Wiik A., van der Woude F. J., Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. Kidney International 1998 53 3 743 753 2-s2.0-15144339407 10.1046/j.1523-1755.1998.00807.x (Pubitemid 28124291)
35. Ludemann J., Csernok E., Ulmer M., Lemke H., Utecht B., Rautmann A., Gross W. L., Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis: immunodiagnostic value, monoclonal antibodies and characterization of the target antigen. Netherlands Journal of Medicine 1990 36 3 157 162 2-s2.0-0025254023 (Pubitemid 20125979)
36. Goldschmeding R., van der Schoot C. E., Ten Bokkel Huinink D., Hack C. E., van den Ende M. E., Kallenberg C. G. M., Von dem Borne Kr. A. E. G., Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. Journal of Clinical Investigation 1989 84 5 1577 1587 2-s2.0-0024432516 (Pubitemid 19272247)
37. Rutgers A., Damoiseaux J., Roozendaal C., Limburg P. C., Stegeman C. A., Cohen Tervaert J. W., ANCA-GBM dot-blot: evaluation of an assay in the differential diagnosis of patients presenting with rapidly progressive glomerulonephritis. Journal of Clinical Immunology 2004 24 4 435 440 2-s2.0-3442895754 10.1023/B:JOCI.0000029115.79266.ae (Pubitemid 39005576)
38. Arranz Ó., Ara J., Rodríguez R., Quintó L., Font J., Mirapeix E., Darnell A., Comparison of anti-PR3 capture and anti-PR3 direct ELISA for detection of antineutrophil cytoplasmic antibodies (ANCA) in long-term clinical follow-up of PR3-ANCA-associated vasculitis patients. Clinical Nephrology 2001 56 4 295 301 2-s2.0-0034813615 (Pubitemid 32923163)
39. Sun J., Fass D. N., Hudson J. A., Viss M. A., Wieslander J., Homburger H. A., Specks U., Capture-ELISA based on recombinant PR3 is sensitive for PR3-ANCA testing and allows detection of PR3 and PR3-ANCA/PR3 immunecomplexes. Journal of Immunological Methods 1998 211 1-2 111 123 2-s2.0-0032004169 10.1016/S0022-1759(97)00203-2 (Pubitemid 28231070)
40. Roggenbuck D., Buettner T., Hoffmann L., Schmechta H., Reinhold D., Conrad K., High-sensitivity detection of autoantibodies against proteinase-3 by a novel third-generation enzyme-linked immunosorbent assay. Annals of the New York Academy of Sciences 2009 1173 41 46 2-s2.0-70049091234 10.1111/j.1749-6632. 2009.04649.x
41. Holle J. U., Csernok E., Fredenhagen G., Backes M., Bremer J. P., Gross W. L., Clinical evaluation of hsPR3-ANCA ELISA for detection of antineutrophil cytoplasmatic antibodies directed against proteinase 3. Annals of the Rheumatic Diseases 2010 69 2 468 469 2-s2.0-75749129898 10.1136/ard.2009.109868
42. Damoiseaux J., Vaessen M., Knapen Y., Csernok E., Stegeman C. A., van Paassen P., Cohen Tervaert J. W., Evaluation of the FIDIS vasculitis multiplex immunoassay for diagnosis and follow-up of ANCA-associated vasculitis and Goodpasture's disease. Annals of the New York Academy of Sciences 2007 1109 454 463 2-s2.0-34848893970 10.1196/annals.1398.051 (Pubitemid 47511388)
43. Kaul R., Johnson K., Scholz H., Marr G., Performance of the BioPlex ™ 2200 Autoimmune Vasculitis kit. Autoimmunity Reviews 2009 8 3 224 227 2-s2.0-58149464892 10.1016/j.autrev.2008.07.033
44. Trevisin M., Pollock W., Dimech W., Savige J., Evaluation of a multiplex flow cytometric immunoassay to detect PR3- and MPO-ANCA in active and treated vasculitis, and in inflammatory bowel disease (IBD). Journal of Immunological Methods 2008 336 2 104 112 2-s2.0-46149123662 10.1016/j.jim.2008.03.012
45. Mahler M., Radice A., Yang W., Bentow C., Seaman A., Bianchi L., Sinico R. A., Development and performance evaluation of novel chemiluminescence assays for detection of anti-PR3 and anti-MPO antibodies. Clinica Chimica Acta 2012 413 7-8 719 726 2-s2.0-84857652808 10.1016/j.cca.2012.01.004
46. Bizzaro N., Antico A., Platzgummer S., Automated antinuclear immunofluorescence antibody screening: a comparative study of six computer-aided diagnostic systems. Autoimmunity Reviews 2014 13 292 298
47. Bonroy C., Verfaillie C., Smith V., Automated indirect immunofluorescence antinuclear antibody analysis is a standardized alternative for visual microscope interpretation. Clinical Chemistry and Laboratory Medicine 2013 51 1771 1779
48. Kivity S., Gilburd B., Agmon-Levin N., Carrasco M. G., Tzafrir Y., Sofer Y., Mandel M., Buttner T., Roggenbuck D., Matucci-Cerinic M., Danko K., Hoyos M. L., Shoenfeld Y., A novel automated indirect immunofluorescence autoantibody evaluation. Clinical Rheumatology 2012 31 3 503 509 2-s2.0-84859785377 10.1007/s10067-011-1884-1
49. Schouwers S., Bonnet M., Verschueren P., Value-added reporting of antinuclear antibody testing by automated indirect immunofluorescence analysis. Clinical Chemistry and Laboratory Medicine 2014 52 547 551
50. Voigt J., Krause C., Rohwader E., Automated indirect immunofluorescence evaluation of antinuclear autoantibodies on HEp-2 cells. Clinical and Developmental Immunology 2012 2012 7 651058 10.1155/2012/651058
51. Wang G., Csernok E., de Groot K., Gross W. L., Comparison of eight commercial kits for quantitation of antineutrophil cytoplasmic antibodies (ANCA). Journal of Immunological Methods 1997 208 2 203 211 2-s2.0-0031469243 10.1016/S0022-1759(97)00154-3 (Pubitemid 28015347)
52. Csernok E., Ahlquist D., Ullrich S., Gross W. L., A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis. Rheumatology 2002 41 11 1313 1317 2-s2.0-0036851423 (Pubitemid 35363808)
53. Csernok E., Holle J., Hellmich B., Willem J., Tervaert C., Kallenberg C. G. M., Limburg P. C., Niles J., Pan G., Specks U., Westman K., Wieslander J., de Groot K., Gross W. L., Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study. Rheumatology 2004 43 2 174 180 2-s2.0-10744221173 10.1093/rheumatology/keh028 (Pubitemid 38219671)
54. Hellmich B., Csernok E., Fredenhagen G., Gross W. L., A novel high sensitivity ELISA for detection of antineutrophil cytoplasm antibodies against proteinase-3. Clinical and Experimental Rheumatology 2007 25 1 S1 S5 2-s2.0-34247536728 (Pubitemid 46656585)
55. Damoiseaux J., Dähnrich C., Rosemann A., Probst C., Komorowski L., Stegeman C. A., Egerer K., Hiepe F., van Paassen P., Stöcker W., Schlumberger W., Tervaert J. W. C., A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for antineutrophil cytoplasmic antibody-associated vasculitis. Annals of the Rheumatic Diseases 2009 68 2 228 233 2-s2.0-58849085096 10.1136/ard.2007.086579
56. Noel N., Andre C., Bengoufa D., Performance evaluation of three assays for the detection of PR3-ANCA in granulomatosis with polyangiitis in daily practice. Autoimmunity Reviews 2013 12 1118 1122
57. Radice A., Bianchi L., Maggiore U., Vaglio A., Sinico R. A., Comparison of PR3-ANCA specific assay performance for the diagnosis of granulomatosis with polyangiitis (Wegener's). Clinical Chemistry and Laboratory Medicine 2013 51 2141 2149
58. Posthuma-Trumpie G. A., Korf J., van Amerongen A., Lateral flow (immuno)assay: its strengths, weaknesses, opportunities and threats. A literature survey. Analytical and Bioanalytical Chemistry 2009 393 2 569 582 2-s2.0-57849115714 10.1007/s00216-008-2287-2 (Pubitemid 50238446)
59. Gordon J., Michel G., Analytical sensitivity limits for lateral flow immunoassays. Clinical Chemistry 2008 54 7 1250 1251 2-s2.0-47549086509 10.1373/clinchem.2007.102491 (Pubitemid 352009707)
60. Bonenberger J., Doumanas M., Overcoming sensitivity limitations of lateral-flow immunoassays with a novel labeling technique. IVD Technology 2006
61. Schulte-Pelkum J., Offermann N., Fooke M., New highly sensitive and specific Lateral Flow Tests for the detection of Proteinase 3, Myeloperoxidase and Glomerular Basement Membrane antibodies. Proceedings of the 8th International Congress on Autoimmunity May 2012 Granada, Spain 234
62. Lucassen R., Schulte-Pelkum J., Petschinka M., Fooke M., New sensitive and reliable Lateral flow assay for the detection of proteinase 3 and myeloperoxidase antibodies. Proceedings of the 10th Dresden Symposium on Autoantibodies 2011 694 695
63. Sowa M., Knütter I., Hiemann R., CytoBead ANCA-a novel indirect immunofluorescence test for the simultaneous detection of anti-neutrophil cytoplasmic antibodies. Proceedins of the 11th Dresden Symposium on Autoantibodies September 2013 Dresden, Germany 271 272
64. Mahler M., Radice A., Sinico R. A., Damoiseaux J., Seaman A., Buckmelter K., Vizjak A., Buchner C., Binder W. L., Fritzler M. J., Cui Z., Performance evaluation of a novel chemiluminescence assay for detection of anti-GBM antibodies: an international multicenter study. Nephrology Dialysis Transplantation 2012 27 1 243 252 2-s2.0-84856631984 10.1093/ndt/gfr203
65. Mahler M., Bentow C., Vizjak A., Multi-center evaluation of a novel chemiluminescent rapid assay for the detection of PR3-ANCA. La Presse Médicale 2013 42 683 684
66. Ito-Ihara T., Muso E., Kobayashi S., Uno K., Tamura N., Yamanishi Y., Fukatsu A., Watts R. A., Scott D. G. I., Jayne D. R. W., Suzuki K., Hashimoto H., A comparative study of the diagnostic accuracy of ELISA systems for the detection of anti-neutrophil cytoplasm antibodies available in Japan and Europe. Clinical and Experimental Rheumatology 2008 26 6 1027 1033 2-s2.0-59149105814
67. Hellmich B., Flossmann O., Gross W. L., Bacon P., Cohen-Tervaert J. W., Guillevin L., Jayne D., Mahr A., Merkel P. A., Raspe H., Scott D. G. I., Witter J., Yazici H., Luqmani R. A., EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Annals of the Rheumatic Diseases 2007 66 5 605 617 2-s2.0-34248218149 10.1136/ard.2006.062711 (Pubitemid 46707128)
68. Vermeersch P., Vervaeke S., Blockmans D., van Hoovels L., Mariën G., Vanmaele H., Bossuyt X., Determination of anti-neutrophil cytoplasmic antibodies in small vessel vasculitis: comparative analysis of different strategies. Clinica Chimica Acta 2008 397 1-2 77 81 2-s2.0-51249101688 10.1016/j.cca.2008.07.026
69. Seck S. M., Dussol B., Brunet P., Burtey S., Clinical features and outcomes of ANCA-associated renal vasculitis. Saudi Journal of Kidney Diseases and Transplantation 2012 23 301 305
70. Sanders J. S. R., Stassen P. M., van Rossum A. P., Kallenberg C. G. M., Stegeman C. A., Risk factors for relapse in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: tools for treatment decisions? Clinical and Experimental Rheumatology 2004 22 6 S-94 S-101 2-s2.0-15044355295 (Pubitemid 41185527)
71. Hoffman G. S., Kerr G. S., Leavitt R. Y., Hallahan C. W., Lebovics R. S., Travis W. D., Rottem M., Fauci A. S., Wegener granulomatosis: an analysis of 158 patients. Annals of Internal Medicine 1992 116 6 488 498 2-s2.0-0026505235
72. Terrier B., Saadoun D., Sène D., Ghillani P., Amoura Z., Deray G., Fautrel B., Piette J.-C., Cacoub P., Antimyeloperoxidase antibodies are a useful marker of disease activity in antineutrophil cytoplasmic antibody-associated vasculitides. Annals of the Rheumatic Diseases 2009 68 10 1564 1571 2-s2.0-70349395712 10.1136/ard.2008.094714
73. Luxton G., Langham R., ANCA serology in the diagnosis and management of ANCA-associated renal vasculitis. Nephrology 2008 13 supplement 2 S17 S23 2-s2.0-47749124271 10.1111/j.1440-1797.2008.00994.x (Pubitemid 352033049)
74. Sinclair D., Stevens J. M., Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies in the diagnosis and monitoring of systemic vasculitides. Annals of Clinical Biochemistry 2007 44 5 432 442 2-s2.0-38449123063 10.1258/000456307781646049 (Pubitemid 351724651)
75. Birck R., Schmitt W. H., Kaelsch I. A., van der Woude F. J., Serial ANCA determinations for monitoring disease activity in patients with ANCA-associated vasculitis: systematic review. American Journal of Kidney Diseases 2006 47 1 15 23 2-s2.0-29244461435 10.1053/j.ajkd.2005.09.022 (Pubitemid 41828262)
76. Papp M., Altorjay I., Lakos G., Tumpek J., Sipka S., Dinya T., Palatka K., Veres G., Udvardy M., Lakatos P. L., Evaluation of the combined application of ethanol-fixed and formaldehyde-fixed neutrophil substrates for identifying atypical perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Clinical and Vaccine Immunology 2009 16 4 464 470 2-s2.0-64549131688 10.1128/CVI.00002-09
77. Papp M., Norman G. L., Altorjay I., Lakatos P. L., Utility of serological markers in inflammatory bowel diseases: gadget or magic? World Journal of Gastroenterology 2007 13 14 2028 2036 2-s2.0-34249047618 (Pubitemid 46795837)
78. Reese G. E., Constantinides V. A., Simillis C., Darzi A. W., Orchard T. R., Fazio V. W., Tekkis P. P., Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease. American Journal of Gastroenterology 2006 101 10 2410 2422 2-s2.0-33749181545 10.1111/j.1572-0241.2006.00840.x (Pubitemid 44477569)
79. Bossuyt X., Serologic markers in inflammatory bowel disease. Clinical Chemistry 2006 52 2 171 181 2-s2.0-31844441031 10.1373/clinchem.2005.058560 (Pubitemid 43185477)
80. Quinton J.-F., Sendid B., Reumaux D., Duthilleul P., Cortot A., Grandbastien B., Charrier G., Targan S. R., Colombel J.-F., Poulain D., Anti-Saccharomyces cerevisiae manna antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1998 42 6 788 791 2-s2.0-7144255517 (Pubitemid 28277217)
81. Ferrante M., Henckaerts L., Joossens M., Pierik M., Joossens S., Dotan N., Norman G. L., Altstock R. T., van Steen K., Rutgeerts P., van Assche G., Vermeire S., New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut 2007 56 10 1394 1403 2-s2.0-34948854194 10.1136/gut.2006.108043 (Pubitemid 47517833)
82. Israeli E., Grotto I., Gilburd B., Balicer R. D., Goldin E., Wiik A., Shoenfeld Y., Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut 2005 54 9 1232 1236 2-s2.0-23744480856 10.1136/gut.2004.060228 (Pubitemid 41192480)
83. Terjung B., Spengler U., Sauerbruch T., Worman H. J., 'Atypical p-ANCA' in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines. Gastroenterology 2000 119 2 310 322 2-s2.0-0033868399 (Pubitemid 30621981)
84. Mowat C., Cole A., Windsor A., Ahmad T., Arnott I., Driscoll R., Mitton S., Orchard T., Rutter M., Younge L., Lees C., Ho G.-T., Satsangi J., Bloom S., Guidelines for the management of inflammatory bowel disease in adults. Gut 2011 60 5 571 607 2-s2.0-79953761841 10.1136/gut.2010.224154
85. Roggenbuck D., Hausdorf G., Martinez-Gamboa L., Reinhold D., Büttner T., Jungblut P. R., Porstmann T., Laass M. W., Henker J., Büning C., Feist E., Conrad K., Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn's disease. Gut 2009 58 12 1620 1628 2-s2.0-72549109556 10.1136/gut.2008.162495
86. Bogdanos D. P., Rigopoulou E. I., Smyk D. S., Roggenbuck D., Reinhold D., Forbes A., Laass M. W., Conrad K., Diagnostic value, clinical utility and pathogenic significance of reactivity to the molecular targets of Crohn's disease specific-pancreatic autoantibodies. Autoimmunity Reviews 2011 11 143 148 2-s2.0-80053987156 10.1016/j.autrev.2011.09.004
87. de Beéck K. O., Vermeire S., Rutgeerts P., Bossuyt X., Antibodies to GP2, the major zymogen granule membrane glycoprotein, in inflammatory bowel diseases. Gut 2012 61 1 162 164 2-s2.0-83555177630 10.1136/gut.2010.233148
88. Op de Beéck K., van den Bergh K., Vermeire S., Decock S., Derua R., Waelkens E., Rutgeerts P., Nevens F., Bossuyt X., Immune reactivity to β -tubulin isotype 5 and vesicular integralmembrane protein 36 in patients with autoimmune gastrointestinal disorders. Gut 2011 60 11 1601 1602 2-s2.0-80053573003 10.1136/gut.2010.222646
89. Vecchi M., Bianchi M. B., Sinico R. A., Radice A., Meucci G., Torgano G., Omodei P., Forzenigo L., Landoni M., Arrigoni M., Pozzi C., de Franchis R., Antibodies to neutrophil cytoplasm in Italian patients with ulcerative colitis: sensitivity, specificity and recognition of putative antigens. Digestion 1994 55 1 34 39 2-s2.0-0028008777 (Pubitemid 24014638)
90. Ooi C. J., Lim B. L., Cheong W. K., Ling A. E., Ng H. S., Antineutrophil cytoplasmic antibodies (ANCAs) in patients with inflammatory bowel disease show no correlation with proteinase 3, lactoferrin, myeloperoxidase, elastase, cathepsin G and lysozyme: a Singapore study. Annals of the Academy of Medicine Singapore 2000 29 6 704 707 2-s2.0-0034329183 (Pubitemid 33710665)
91. Elzouki A. N., Eriksson S., Lofberg R., Nassberger L., Wieslander J., Lindgren S., The prevalence and clinical significance of 1-antitrypsin deficiency (PiZ) and ANCA specificities (proteinase 3, BPI) in patients with ulcerative colitis. Inflammatory Bowel Diseases 1999 5 4 246 252 2-s2.0-0033228751
92. Xu J., Yang C.-H., Chen X.-Y., Li X.-H., Dai M., Xiao S.-D., A subset of ulcerative colitis with positive proteinase-3 antineutrophil cytoplasmic antibody. World Journal of Gastroenterology 2008 14 45 7012 7015 2-s2.0-63449113741 10.3748/wjg.14.7012
93. Tsiveriotis K., Tsirogianni A., Pipi E., Soufleros K., Papasteriades C., Antineutrophil cytoplasmic antibodies testing in a large cohort of unselected greek patients. Autoimmune Disorders 2011 2011 9 626495 10.4061/2011/626495
94. Joossens S., Reinisch W., Vermeire S., Sendid B., Poulain D., Peeters M., Geboes K., Bossuyt X., Vandewalle P., Oberhuber G., Vogelsang H., Rutgeerts P., Colombel J., The value of serologic markers in indeterminate colitis: a prospective follow-up study. Gastroenterology 2002 122 5 1242 1247 2-s2.0-0036242774 (Pubitemid 34465166)
95. Geboes K., Colombel J.-F., Greenstein A., Jewell D. P., Sandborn W. J., Vatn M. H., Warren B., Riddell R. H., Indeterminate colitis: a review of the concept-what's in a name? Inflammatory Bowel Diseases 2008 14 6 850 857 2-s2.0-46049120295 10.1002/ibd.20361 (Pubitemid 351898070)
96. Civan J. M., Gilbert C. R., Kastenberg D. M., Pulmonary capillaritis: a rare extra-intestinal manifestation of inflammatory bowel disease. American Journal of Gastroenterology 2011 106 4 804 805 2-s2.0-79953772750 10.1038/ajg.2011.46
97. Beccastrini E., Emmi G., Squatrito D., Nesi G., Almerigogna F., Emmi L., Lobular panniculitis with small vessel vasculitis associated with ulcerative colitis. Modern Rheumatology 2011 21 5 528 531 2-s2.0-84855649895 10.1007/s10165-011-0428-5
98. Qian Q., Cornell L., Chandan V., Hartman R., Caples S., Hemorrhagic colitis as a presenting feature of Wegener granulomatosis. Journal of Gastrointestinal and Liver Diseases 2010 19 4 445 447 2-s2.0-79955659348
99. Amador-Patarroyo M. J., Arbelaez J. G., Mantilla R. D., Sjogren's syndrome at the crossroad of polyautoimmunity. Journal of Autoimmunity 2012 39 199 205
100. Pagnoux C., Mahr A., Cohen P., Guillevin L., Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg-Strauss syndrome, or rheumatoid arthritis-associated vasculitis. Medicine 2005 84 2 115 128 2-s2.0-15744373536 10.1097/01.md. 0000158825.87055.0b (Pubitemid 40418640)
101. Burke A. P., Sobin L. H., Virmani R., Localized vasculitis of the gastrointestinal tract. American Journal of Surgical Pathology 1995 19 3 338 349 2-s2.0-0028901745